| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $123.3M | +19.4% |
| Cost of Revenue | $92.8M | +27.2% |
| Gross Profit | $30.5M | +0.7% |
| R&D Expense | $455K | +9.9% |
| SG&A Expense | $25.2M | +19.8% |
| Operating Income | $4.9M | -45.1% |
| Pre-tax Income | $4.7M | -43.6% |
| Income Tax | $995K | -50.4% |
| Net Income | $3.7M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | -35.1% |
| Accounts Receivable | $8.1M | +3.5% |
| Inventory | $4.8M | +45.5% |
| Current Assets | $21.9M | -7.2% |
| Total Assets | $47.1M | +4.3% |
| Current Liabilities | $17.0M | +2.0% |
| Total Liabilities | $22.2M | -13.1% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.2M | -55.5% |
| Capital Expenditures | $5.1M | +548.2% |
| Investing Cash Flow | -$5.1M | -255.8% |
| Financing Cash Flow | -$4.0M | -11.5% |
| Free Cash Flow | $82K | -99.2% |
| -43.4% |
| EPS (Basic) | $0.10 | -44.4% |
| EPS (Diluted) | $0.09 | -47.1% |
| Stockholders' Equity |
| $24.9M |
| +27.1% |